ARA Content
?>
Download eBooks and Software
 100 Healthy Raw Snacks And Treats
Healthy, Natural, Sugar Free, No Cook Recipes. Living Nutrition For Living Bodies. Learn How Simple It Is To Improve Your Health With These 100 Quick And Easy Recipes
Moving And Living In Spain
Get 50% Payout! Everything You Need To Know About Moving And Living In Spain. From Property Buying, Health Care, Immigration,permits,tax,language,finding Work. Expats Guide For Your Life Under The Spanish Sun. Get Tools Here: www.spain-tips.com/affiliate
Chocolate Recipe Guilt Free
Attention Affiliates. This Ebook Is Hugely Popular Within The Raw, Health Food Niche Converting Over 11% When Book Reviewed In Newsletter Or Emailed Direct To Your List. Good Info, Natural Ingredients, 70 + Original, Healthy, Raw Chocolate Recipes, Photos
Articles > Healtha Cold; Starve a Tumor
by: ARA Content
(ARA) - One of the most exciting developments in modern medicine has been the discovery that cancerous tumors have the potential of being "starved" out of existence, or at least into dormancy. Scientists, doctors and, of course, patients, are all anticipating the prospect that cancer patients may take a drug that will stop a tumor in its track by cutting off the blood supply that nourishes it.
At the core of this medical breakthrough was the discovery that every tumor needs to "recruit" its own blood supply to flourish and grow. Scientists also found out that tumors actively "participated" in this process by secreting certain growth chemicals that would attract blood vessels to the tumor. Having identified this process, the next step was to determine if drugs could be created that could somehow arrest or reverse the progress of blood vessels amassing around a tumor.
The result has been a highly dynamic and exciting area of medicine called anti-angiogenesis (meaning "against the formation of new blood vessels") that focuses on inhibiting the growth of cancer by developing drugs that will prevent tumors from growing in size.
Currently, there are several drug companies that are on the cusp of introducing drugs that will work by the process of anti-angiogenesis. Generally speaking, the drugs seek to improve survival rates of cancer patients, as well as increase the length of time that patients survive. And unlike conventional cancer therapies that have punishing side effects, the new drugs seem to demonstrate few or no side effects for most people. Furthermore, some of the studies show that by utilizing both conventional treatments like radiation and/or chemotherapy in conjunction with anti-angiogenesis drugs, the cumulative effect is even more powerful.
One highly regarded company that is at the forefront of developing anti-angiogenesis drugs is Aeterna Laboratories, based in Quebec, Canada and traded on the Nasdaq market under the ticker symbol, AELA. The company's premier product, Neovastat, is currently being tested in clinical trials for a variety of cancers including lung, renal (kidney) and multiple myeloma (bone marrow). The results for the renal and multiple myeloma tests are scheduled to wrap up by the end of 2002 and, if conclusive, will be submitted to the Federal Drug Administration for review.
Out of all the drugs under development, Neovastat is unique because of its multi-functionality, which is its ability to shut down two pathways recognized as being responsible for promoting angiogenesis (in contrast to other drugs which just block one pathway). In clinical trials, Neovastat has been shown to have no side effects in most people. This is obviously a big advantage for people who know the agony of nausea, exhaustion and/or hair loss that can accompany chemotherapy drugs. In tests, Neovastat has been given to people in liquid oral form, generally the preferable form of drug delivery for patients.
If you are a cancer patient interested in clinical trial participation, you can get information about current trials by calling (888)-349-3232 If you are an oncologist, please contact Claude Hariton, Ph.D., vice president of Clinical and Regulatory Affairs at (418) 652-8525 ext. 306. To learn more about anti-angiogenesis drugs and Aeterna Laboratories, visit the Aeterna Web site at www.aeterna.com.
?>
News on Health
Health Net Announces Appearance at Sanford C. Bernstein’s 28th Strategic Decisions Conference
Health Net, Inc. today announced that members of its management team are scheduled to present at Sanford C. Bernstein’s 28th Strategic Decisions Conference on May 30, 2012, at approximately 9:00 a.m. Health Highlights: May 24, 2012
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Extend Health Bringing 500+ Jobs to Richardson, Texas
Extend Health, Inc., a leading provider of health benefit management services, including the nation’s largest private Medicare exchange, today celebrated the opening of the first of two new service centers in Richardson, Texas, that together expect to bring more than 500 new jobs to the greater Dallas–Fort Worth area. Chronic diseases are health ministers' target -WHO
GENEVA (Reuters) - The world's health ministers have agreed to try to cut premature deaths from chronic illnesses such as cardiovascular disease and cancer by 25 percent by 2025, the World Health Organisation (WHO) said on Friday. Heart disease, diabetes, cancers and chronic respiratory illnesses are the biggest killer globally, according to the United Nations agency. They account for 36 million ... Health and fitness agenda: Mobile Health Summit
Coming up, Cape Town puts mobile health technologies on the table with the Mobile Health Summit, while World No Tobacco Day aims to snuff out smoking around the globe.
|
